Alpha-1-fetoprotein.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 66111)

Published in Clin Gastroenterol on September 01, 1976

Authors

E Alpert

Articles by these authors

(truncated to the top 100)

The pathogenesis of arthritis associated with viral hepatitis. Complement-component studies. N Engl J Med (1971) 3.31

Maternal serum AFP secreening. N Engl J Med (1978) 3.17

Experimental mosquito-transmission of Plasmodium knowlesi to man and monkey. Am J Trop Med Hyg (1968) 2.89

Prenatal diagnosis of neural tube defects. III. A reevaluation of the alpha-fetoprotein assay. Obstet Gynecol (1977) 2.24

The pathogenesis of arthritis associated with acute hepatitis-B surface antigen-positive hepatitis. Complement activation and characterization of circulating immune complexes. J Clin Invest (1975) 2.13

Results and benefits of a maternal serum alpha-fetoprotein screening program. JAMA (1984) 1.82

A method for increasing the sensitivity of radial-immunodiffusion assay. Lancet (1970) 1.70

Hepatitis-associated antigen and hepatoma in the U.S. Lancet (1971) 1.64

Cell-mediated immunity in acute and chronic hepatitis. J Clin Invest (1975) 1.63

Alpha-fetoprotein in a patient with gastric carcinoma metastatic to the liver. N Engl J Med (1971) 1.59

Use of older donor livers is associated with more extensive ischemic damage on intraoperative biopsies during liver transplantation. Liver Transpl Surg (1999) 1.54

Elevation of CA-125 level is due to abdominal distension in liver transplantation candidates. Transplantation (2001) 1.40

The effect of gestational age on the detection rate of Down's syndrome by maternal serum alpha-fetoprotein screening. Am J Obstet Gynecol (1991) 1.39

Liver transplantation: therapeutic option in end-stage liver disease. Tex Med (1988) 1.37

Clinical studies on the radioimmunodetection of tumors containing alpha-fetoprotein. Cancer (1980) 1.34

Alpha-fetoprotein (AFP) in benign liver disease. Evidence that normal liver regeneration does not induce AFP synthesis. Gastroenterology (1978) 1.32

Natural history of benign esophageal stricture treated by dilatation. Gastroenterology (1983) 1.27

Carcino-foetal human liver ferritins. Nature (1973) 1.27

Human -fetoprotein. Isolation, characterization, and demonstration of microheterogeneity. J Biol Chem (1972) 1.26

Human isoferritins: organ specific iron and apoferritin distribution. Br J Haematol (1975) 1.23

Inflammatory bowel disease associated circulating immune complexes. Gut (1980) 1.19

Abnormality in tissue isoferritin distribution in idiopathic haemochromatosis. Nature (1974) 1.19

Prenatal diagnosis of neural tube defects. I. Problems and pitfalls: analysis of 2495 cases using the alpha-fetoprotein assay. Obstet Gynecol (1976) 1.16

Inflammatory bowel disease: study of cell mediated cytotoxicity for isolated human colonic epithelial cells. Gut (1980) 1.16

Effect of multiparity on human maternal hypersensitivity to foetal antigen. Nature (1973) 1.15

Beta-fetoprotein: identification as normal liver ferritin. Lancet (1973) 1.13

A double-blinded, randomized trial of hydrocortisone in acute hepatic failure. The Acute Hepatic Failure Study Group. Dig Dis Sci (1991) 1.13

Ocular neuroprotection by siRNA targeting caspase-2. Cell Death Dis (2011) 1.12

The value of alpha-fetoprotein in the prenatal diagnosis of neural tube defects. J Pediatr (1974) 1.08

Liver transplantation for cholesteryl ester storage disease. J Pediatr Gastroenterol Nutr (1991) 1.08

CD44 involvement in experimental collagen-induced arthritis (CIA). J Autoimmun (1999) 1.08

Lysyl oxidase and collagenase in experimental acute and chronic liver injury. Gastroenterology (1982) 1.04

The roles of hyperglycaemia and oxidative stress in the rise and collapse of the natural protective mechanism against vascular endothelial cell dysfunction in diabetes. Arch Physiol Biochem (2007) 1.04

-fetoprotein in human hepatoma: improved detection in serum, and quantitative studies using a new sensitive technique. Gastroenterology (1971) 1.00

Helicobacter heilmannii-like spiral bacteria in gastric mucosal biopsies. Prevalence and clinical significance. Arch Pathol Lab Med (1995) 0.99

A prospective trial of D-penicillamine in primary biliary cirrhosis. N Engl J Med (1982) 0.98

Arthritis associated with chronic active hepatitis: complement activation and characterization of circulating immune complexes. Gastroenterology (1975) 0.97

Carcinoembryonic antigen: evidence for multiple antigenic determinants and isoantigens. Proc Natl Acad Sci U S A (1975) 0.97

Gamma G subgroups in human fetal, cord, and maternal sera. Clin Immunol Immunopathol (1973) 0.97

Alpha-fetoprotein levels in normal adults. Am J Med Sci (1992) 0.94

Downregulation of phorbol 12-myristate 13-acetate-induced tumor necrosis factor-alpha and interleukin-1 beta production and gene expression in human monocytic cells by human alpha-fetoprotein. Hepatology (1995) 0.92

Integrating routine inquiry about domestic violence into daily practice. Ann Intern Med (1999) 0.92

Prenatal diagnosis of neural tube defects. II. Analysis of false positive and false negative alpha-fetoprotein results. Obstet Gynecol (1976) 0.92

Radioimmunodetection of cancer with radiolabeled antibodies to alpha-fetoprotein. Cancer Res (1980) 0.91

Galactosyltransferase isoenzyme II in the detection of pancreatic cancer: comparison with radiologic, endoscopic, and serologic tests. N Engl J Med (1981) 0.89

Factors affecting the prognosis of primary liver carcinoma. J Clin Oncol (1988) 0.89

Efficacy of mycophenolate mofetil combined with very low-dose cyclosporine microemulsion in long-term liver-transplant patients with renal dysfunction. Transplantation (2003) 0.88

Chromosomal structure and localization of the human alpha-fetoprotein gene. Ann N Y Acad Sci (1983) 0.88

Isolation and partial characterization of a specific alpha-fetoprotein receptor on human monocytes. J Clin Invest (1992) 0.88

Hereditary persistence of alpha-fetoprotein. Gastroenterology (1990) 0.88

Secretion by a hybridoma of antibodies against human alpha-fetoprotein. N Engl J Med (1980) 0.88

The effect of purified alpha-fetoprotein on in vitro assays of cell-mediated immunity. Cell Immunol (1977) 0.86

Characterization and subunit analysis of ferritin isolated from normal and malignant human liver. Cancer Res (1975) 0.86

Congenital deficiency of alpha-fetoprotein. Am J Obstet Gynecol (1992) 0.85

Isoelectric focusing of human fetoprotein: an aid in purification and characterization of microheterogeneity. Ann N Y Acad Sci (1973) 0.85

Alteration of aldolase isozymes in serum and tissues of patients with cancer and other diseases. J Clin Lab Anal (1994) 0.84

Multiple antigens as marker substances in germinal tumors of the testis. J Natl Cancer Inst (1977) 0.84

Gastric toxoplasmosis in acquired immunodeficiency syndrome: antemortem diagnosis with histopathologic characterization. Gastroenterology (1996) 0.84

Serum -fetoprotein in hepatoma patients after liver transplantation. Gastroenterology (1971) 0.83

Maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, and unconjugated estriol levels in midtrimester trisomy 18 pregnancies. Am J Obstet Gynecol (1992) 0.83

Prenatal diagnosis of neural tube defects. VIII. The importance of serum alpha-fetoprotein screening in diabetic pregnant women. Am J Obstet Gynecol (1982) 0.83

Absence of alpha-1-fetoprotein antigen or antibody in maternal sera. Lancet (1970) 0.82

Alpha-1-fetoprotein: serologic marker of human hepatoma and embryonal carcinoma. Natl Cancer Inst Monogr (1972) 0.82

The immunochemical complexity of CEA: a golden dream or molecular nightmare? Cancer (1978) 0.82

Evaluation of CI-564, A 1:1 mixture of cycloguanil pamoate (CI-501) and 4,4'-diacetylaminodiphenylsulfone (CI-556), against multiresistant falciparum malarias. Am J Trop Med Hyg (1967) 0.82

Arthritis and rash. Clues to anicteric viral hepatitis. Arch Intern Med (1974) 0.82

Primary hepatic tumor. Gastroenterology (1978) 0.82

Sequential changes of serum complement in HAA related arthritis. N Engl J Med (1972) 0.81

Letter: Immunoenzymatic assay for alpha-fetoprotein. Lancet (1974) 0.81

Failure to detect circulating immune complexes in allergic patients on injection therapy. Clin Allergy (1979) 0.81

Repeated balloon dilation of a severe colonic stricture. Gastrointest Endosc (1987) 0.80

Human alpha1-fetoprotein (AFP): developmental biology and clinical significance. Prog Liver Dis (1976) 0.80

Prenatal diagnosis of neural tube defects. IV. Maternal serum alpha-fetoprotein screening. Obstet Gynecol (1980) 0.80

Immunohistochemical localization of alpha1-acid-glycoprotein in human liver parenchymal cells. Histochemistry (1977) 0.79

Radioimmunoassay of aldolase A. Determination of normal serum levels and increased serum concentration in cancer patients. Cancer (1983) 0.79

Alpha 1 -fetoprotein content of gastric carcinoma and hepatic metastases. Am J Dig Dis (1973) 0.79

Carcinofetal human isoferritins. Ann N Y Acad Sci (1975) 0.79

Assessment of mitochondrial function in vivo with a breath test utilizing alpha-ketoisocaproic acid. Hepatology (1989) 0.79

Subunit-specific radioimmunoassay for aldolase A, B, and C subunits: clinical significance. Ann N Y Acad Sci (1983) 0.78

Structural integrity of the human albumin gene in congenital analbuminemia. Biochem Biophys Res Commun (1983) 0.78

Immunosuppressive characteristics of human AFP: effect on tests of cell mediated immunity and induction of human suppressor cells. Immunol Commun (1978) 0.78

Cyclosporine peak levels provide a better correlation with the area-under-the-curve than trough levels in liver transplant patients treated with neoral. Transplant Proc (1998) 0.78

Human alpha-fetoprotein. Immunochemical analysis of isoproteins. Ann N Y Acad Sci (1975) 0.77

Pathogenesis of arthritis associated with viral hepatitis. Med Chir Dig (1972) 0.77

Leukoreduction and acute rejection in liver transplantation: an interim analysis. Transplant Proc (2004) 0.77

Human aldolase B serum levels: a marker of liver injury. Hepatology (1984) 0.77

Decreased serum aldolase B levels in patients with malignant tumors. Cancer (1988) 0.77

Serum aldolase isozyme levels in patients with cerebrovascular diseases. Am J Med Sci (1990) 0.77

Do biliary endoprostheses decrease biliary complications after liver transplantation? Transplant Proc (2003) 0.76

Studies on carcino embryonic antigen (CEA): effect of carbohydrate and synthetic glycopeptides on CEA competitive-inhibition radioimmunoassays. Immunochemistry (1976) 0.76

Optimal time points for the prediction of the area-under-the-curve in liver transplant patients receiving tacrolimus. Transplant Proc (1998) 0.76

Aflatoxin-induced hepatic injury in the African monkey. Arch Environ Health (1970) 0.76

Diagnostic procedures in the evaluation of hepatic diseases. Functional evaluation: carcinoembryonic antigen (CEA) and alphafetoprotein (AFP) as tumor markers of the liver. Lab Res Methods Biol Med (1983) 0.75

Immune regulation in inflammatory bowel disease: absence of a serum inhibitor of suppressor cell function. Clin Exp Immunol (1980) 0.75

Sounding board: Antenatal diagnosis, alpha fetoprotein and the FDA. N Engl J Med (1976) 0.75

Hepatitis-associated antigen in patients with cancer. Yale J Biol Med (1972) 0.75

Normal serum alpha-fetoprotein levels during mid-pregnancy. N Engl J Med (1981) 0.75

Radioimmunoassay for human aldolase A. Clin Chim Acta (1981) 0.75

Human albumin synthesis via an albumin precursor in liver tissue slices. Experientia (1981) 0.75

A novel approach to experimentally estimating the number of reactive epitopes on multivalent antigens. Tumour Biol (1989) 0.75